- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Trial Search
Trial Name | Prevention Option | Phase | Start Date | Sponsors | Countries | Population | Candidate(s) | Status |
---|---|---|---|---|---|---|---|---|
Be PrEPared - The Antwerp PrEP Project | PrEP | Demo Project | September 2015 | ITM, TBM, IWT | Belgium | MSM | TDF/FTC (Truvada) | Ongoing |
Partners PrEP OLE | PrEP | Open Label | July 2011 | Bill & Melinda Gates Foundation; NIH; USAID | Kenya, Uganda | TDF/FTC (Truvada) | Completed | |
Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth) | PrEP | Demo Project | November 2014 | New York University | Kenya, United States of America | Women, Men | TDF/FTC (Truvada) | Completed |
Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project) | PrEP | Open Label | February 2015 | Emory University | South Africa | Men, MSM | TDF/FTC (Truvada) | Ongoing |
AMPrEP (Amsterdam PrEP) | PrEP | Demo Project | June 2015 | Academic Medical Center, PHSA | Netherlands | Men, MSM | Ongoing | |
PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples | PrEP | Open Label | July 2014 | United States of America | Women, Men | Ongoing | ||
HPTN 077 | PrEP | II | February 2015 | National Institute of Allergy and Infectious Diseases (NIAID) | United States of America, Brazil, Malawi, South Africa | Women, Men | Cabotegravir (GSK 744) | Completed |
HPTN 076 | PrEP | II | October 2014 | PATH, Bill and Melinda Gates Foundation, NIAID, NIH | United States of America, South Africa, Zimbabwe | Women | TMC 278 | Completed |
CDC 494 | PrEP | Open Label | Botswana Ministry of Health, CDC, Gilead | Botswana | Women, Men | Completed | ||
Sisters Antiretroviral therapy Programme for Prevention of HIV –an Integrated Response (SAPPH-Ire) | PrEP | Demo Project | July 2014 | Centre for Sexual Health and HIV/AIDS Research Zimbabwe; University College London; London School of Hygiene and Tropical Medicine ; RTI; DFID; UNFPA | Zimbabwe | Women | TDF/FTC (Truvada) | Ongoing |
LAC PATH PrEP Demo Project | PrEP | Demo Project | California HIV/AIDS Research Program of the University of California; LA County HIV & STD Program; Los Angeles Gay and Lesbian Center; OASIS Clinic; AIDS Project LA; UCLA | United States of America | MSM | TDF/FTC (Truvada) | Completed | |
The Demo Project | PrEP | Demo Project | October 2014 | National Institute of Allergy and Infectious Diseases of the NIH | United States of America | MSM | TDF/FTC (Truvada) | Completed |
PrEPBrasil | PrEP | Open Label | October 2014 | University of Sao Paulo; Centro de Referência e Treinamento DST AIDS; Oswaldo Cruz Foundation | Brazil | MSM | TDF/FTC (Truvada) | Ongoing |
Wits Reproductive Health and HIV Institute | PrEP | Demo Project | November 2014 | World Health Organization, UNAIDS, O'Neil Institute of Georgetown University, London School of Hygiene and Tropical Medicine, Imperial College London; | South Africa | Women, HIV positive | TDF/FTC (Truvada) | Planned |
PRELUDE Study | PrEP | Demo Project | September 2014 | Kirby Institute; AIDS Council of New South Wales (ACON) and Positive Life New South Wales | Australia | Women, Men | TDF/FTC (Truvada) | Ongoing |
VicPrEP Demonstration Project | PrEP | Demo Project | July 2014 | Victorian Government | Australia | Women, Men, MSM | TDF/FTC (Truvada) | Ongoing |
Benin Demonstration Project | PrEP | Demo Project | October 2014 | CHU de Quebec | Benin | Women | TDF/FTC (Truvada) | Ongoing |
Partners PrEP | PrEP | III | May 2008 | Bill and Melinda Gates Foundation, University of Washington | Kenya, Uganda | Women, Men | TDF, TDF/FTC (Truvada) | Completed |
CDC 4323 | PrEP | II | February 2005 | AIDS Research Consortium of Atlanta, Fenway Health, San Francisco Department of Public Health, US CDC | United States of America | MSM | TDF | Completed |
CDC 4370 (Bangkok Tenofovir Study) | PrEP | III, II | June 2005 | Bangkok Metropolitan Administration Medical College and Vajira Hospital, Thailand Ministry of Health, US CDC | Thailand | Injecting drug users | TDF | Completed |